Print 26 August 2015
SAN DIEGO – August 26, 2015 - Epic Sciences, Inc. (“Epic Sciences”), announced today the appointment of Dave Henderson as Epic Sciences’ chief information officer (CIO). Mr. Henderson has more than 20 years of experience in information technologies at companies including Sequenom, Inc., CBS Corporation, and Paramount Pictures Corporation.
“As Epic Sciences is advancing our no cell left behind® platform, we look forward to working with Dave who has extensive experience implementing enterprise solutions for global companies in regulated environments,” said Murali Prahalad, Ph.D., President and CEO of Epic Sciences. “In particular, Dave’s experience in strategic planning, information technology development and production support will be invaluable as we launch laboratory developed diagnostic tests, grow our biopharma and translational research partnerships and eventually develop a portfolio of globally-distributed in vitro diagnostic products.”
“The team at Epic Sciences is advancing an impressive platform to supply critical and actionable insights about the status and therapeutic response of a patient’s cancer across each clinical decision point,” said Mr. Henderson. “This is a tremendous opportunity to contribute to the company’s continued rapid growth as well as help shape a new paradigm for cancer care.”
As CIO for Sequenom, Mr. Henderson was a key member of an executive team that developed a commercialization plan for the company, implementing systems to support its ISO certification, FDA submissions, and laboratory developed diagnostic tests, which enabled Sequenom’s rapid scale up to $162 million in annual revenues. As Vice President, TV Systems Support for Paramount Pictures Corporation, Mr. Henderson provided global operational support for enterprise systems responsible for $1 billion in revenue and was part of the executive team executing various mergers and acquisitions including the merger of Paramount Pictures with CBS Corporation. Mr. Henderson is on the Management Information Systems Advisory Board for San Diego State University, College of Business Administration and an active member of the Society for Information Management.
Further information is available on the Company's website, www.epicsciences.com.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.